Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 58: e191042, 2022. tab, graf
Article in English | LILACS | ID: biblio-1394057

ABSTRACT

Abstract L-Asparaginase (L-ASNase) is a biopharmaceutical used for acute lymphoblastic leukaemia (ALL) treatment, dramatically increasing the patients' chance of cure. However, its production and distribution in developing countries were disrupted because of its low profitability, which caused great concern among patients. This study evaluates the feasibility of combining fractional precipitation and aqueous two-phase systems (ATPS) to purify L-ASNase from a low-grade product, commercially known as Acrylaway® L. The ATPS purification results were not particularly expressive compared to the two-step purification process composed of ethanol precipitation and gel filtration, which was able to recover the target molecule with a purification factor over 5 fold. Thus, we studied a purification process capable of manufacturing pharmaceutical grade L-ASNase from a commercially available low-grade raw material; however, improvements regarding its throughput must be achieved, and high purity is the first step to apply it as a new biopharmaceutical product. The proposed process could pose as a short-time solution to mitigate its shortage while a cost-effective production plant is being developed.


Subject(s)
Asparaginase/isolation & purification , Fractional Precipitation/methods , Antineoplastic Agents/isolation & purification , Feasibility Studies , Chromatography, Gel , Cost-Benefit Analysis
2.
Braz. j. microbiol ; 41(1): 173-178, Jan.-Mar. 2010. tab
Article in English | LILACS | ID: lil-531749

ABSTRACT

L-asparaginase is an anti-neoplastic agent used in the lymphoblastic leukaemia chemotherapy. In the present study a novel strain, Streptomyces gulbargensis was explored for the production of extra-cellular L-asparaginase using groundnut cake extract. The optimum pH, temperature, inoculum size and agitation speed for enzyme production were pH 8.5, 40ºC, 1x10(8)spores/ml and 200 rev/min respectively. Maltose (0.5 percent) and L-asparagine (0.5 percent) proved to be the best carbon and nitrogen sources respectively. The enzyme was purified 82.12 fold and the apparent molecular weight of the enzyme was found to be 85 kDa. The optima pH and temperature for the enzyme were 9.0 and 40ºC respectively. The enzyme was more stable at the alkaline pH than at the acidic one and it retained 55 percent of the activity at 80ºC for 60 min.


Subject(s)
Asparaginase/analysis , Asparaginase/isolation & purification , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Streptomyces/genetics , Streptomyces/isolation & purification , Enzyme Activation , Food Samples , Methods , Methods
3.
J Environ Biol ; 2007 Jul; 28(3): 645-50
Article in English | IMSEAR | ID: sea-113712

ABSTRACT

The actinomycete strain LA-29 isolated from the gut contents of the fish, Mugil cephalus of the Vellar estuary showed excellent L-asparaginase activity The enzyme was purified 18-fold and the final recovery of protein was 1.9%, which exhibited an activity of 13.57 IU/mg protein. The partially purified L-asparaginase inhibited the growth of leukemia cells in male wistar rats. Average survival period of the rats was more in an optimum enzyme dose of 100 units and the survival period was less when the dosages were increased and at the same time the enzyme became less effective when the dosages were decreased. Higher survival of 17.2 days was recorded when 100 units of the enzyme was given in three intermittent doses (50/25/25 units) at the interval of 24 hr. Analysis of cell components of the strain LA-29 has revealed the wall type-I which is the characteristic of the genus Streptomyces. Further the morphological, physiological and biochemical features along with the micromorphological results obtained for the strain LA-29 were compared with that of the Streptomyces species found in Bergey's Manual of Determinative Bacteriology and the strain LA-29 has been tentatively identified as Streptomyces canus.


Subject(s)
Actinobacteria/enzymology , Animals , Antineoplastic Agents/isolation & purification , Asparaginase/isolation & purification , Cell Line, Tumor , Gastrointestinal Contents/microbiology , Leukemia/drug therapy , Male , Neoplasm Transplantation , Rats , Rats, Wistar , Smegmamorpha/microbiology
4.
Indian J Biochem Biophys ; 2006 Dec; 43(6): 391-4
Article in English | IMSEAR | ID: sea-29079

ABSTRACT

L-Asparaginase shows antileukemic activity and is generally administered in the body in combination with other anticancer drugs like pyrimidine derivatives. In the present study, L-asparaginase was purified from a bacteria Erwinia carotovora and the effect of a dihydropyrimidine derivative (1-amino-6-methyl-4-phenyl-2-thioxo, 1,2,3,4-tetrahydropyrimidine-5-carboxylic acid methyl ester) was studied on the kinetic parameters Km and Vmax of the enzyme using L-asparagine as substrate. The enzyme had optimum activity at pH 8.6 and temperature 35 degrees C, both in the absence and presence of pyrimidine derivative and substrate saturation concentration at 6 mg/ml. For the enzymatic reaction in the absence and presence (1 to 3 mg/ml) of dihydropyrimidine derivative, Km values were 7.14, 5.26, 4.0, and 5.22 M, and Vmax values were 0.05, 0.035, 0.027 and 0.021 mg/ml/min, respectively. The kinetic values suggested that activity of enzyme was enhanced in the presence of dihydropyrimidine derivative.


Subject(s)
Asparaginase/isolation & purification , Kinetics , Pectobacterium carotovorum/enzymology , Pyrimidines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL